GEROSA, MARIA
GEROSA, MARIA
Dipartimento di Scienze Cliniche e di Comunità
Fluctuation of Anti–Domain 1 and Anti–β2‐Glycoprotein I Antibody Titers Over Time in Patients With Persistently Positive Antiphospholipid Antibodies
2023 C.B. Chighizola, F. Pregnolato, D. Andrade, M. Tektonidou, V. Pengo, G. Ruiz‐irastorza, H.M. Belmont, M. Gerosa, P. Fortin, D.W. Branch, L. Andreoli, M.A. Petri, R. Cervera, J.S. Knight, R. Willis, M. Efthymiou, H. Cohen, D. Erkan, M.L. Bertolaccini
Immunology of pregnancy and reproductive health in autoimmune rheumatic diseases. Update from the 11th International Conference on Reproduction, Pregnancy and Rheumatic Diseases
2023 L. Andreoli, C.B. Chighizola, L. Iaccarino, A. Botta, M. Gerosa, V. Ramoni, C. Tani, B. Bermas, A. Brucato, J. Buyon, I. Cetin, C.D. Chambers, M.E.B. Clowse, N. Costedoat-Chalumeau, M. Cutolo, S. De Carolis, R. Dolhain, E.M. Fazzi, F. Förger, I. Giles, I. Haase, M. Khamashta, R.A. Levy, P.L. Meroni, M. Mosca, C. Nelson-Piercy, L. Raio, J. Salmon, P. Villiger, M. Wahren-Herlenius, M. Wallenius, C. Zanardini, Y. Shoenfeld, A. Tincani
Global comment on the use of hydroxychloroquine during the periconception period and pregnancy in women with autoimmune diseases
2023 K. Schreiber, I. Giles, N. Costedoat-Chalumeau, C. Nelson-Piercy, R.J. Dolhain, M. Mosca, F. Förger, R. Fischer-Betz, A. Molto, A. Tincani, E. Pasquier, B. Marin, E. Elefant, J. Salmon, B.L. Bermas, L. Sammaritano, M.E.B. Clowse, C. Chambers, J. Buyon, S.A. Inoue, N. Agmon-Levin, S. Aguilera, S.A. Emadi, J. Andersen, D. Andrade, A. Antovic, L. Arnaud, A.A. Christiansen, T. Avcin, S. Badreh-Wirström, G. Bertsias, I. Bini, A. Bobirca, W. Branch, A. Brucato, I. Bultink, S. Capela, I. Cecchi, R. Cervera, C. Chighizola, C. Cobilinschi, M.J. Cuadrado, D. Dey, O. Etomi, G. Espinosa, J. Flint, J. Fonseca, R. Fritsch-Stork, M. Gerosa, B. Glintborg, C.G. Skorpen, B. Goulden, C. Graversgaard, I. Gunnarsson, L. Gupta, M. Hetland, K. Hodson, B.J. Hunt, D. Isenberg, S. Jacobsen, M. Khamashta, R. Levy, L. Linde, J. Lykke, Y. Meissner, L. Moore, E. Morand, S. Navarra, D. Opris-Belinski, M. Østensen, H. Ozawa, L.F. Perez-Garcia, M. Petri, G.J. Pons-Estel, M. Radin, L. Raio, A. Rottenstreich, G. Ruiz-Irastorza, S.R. Tunjić, M. Rygg, S. Sciascia, A. Strangfeld, E. Svenungsson, M. Tektonidou, A. Troldborg, E. Vinet, J. Vojinovic, A. Voss, M. Wallenius, L. Andreoli
Impact of low-dose acetylsalicylic acid on pregnancy outcome in systemic lupus erythematosus: results from a multicentre study
2022 C. Tani, D. Zucchi, I. Haase, M. Gerosa, M. Larosa, L. Cavagna, A. Bortoluzzi, F. Crisafulli, J. Mucke, F. Strigini, L. Baglietto, M. Fornili, F. Monacci, E. Elefante, R. Erra, E. Bellis, M. Padovan, L. Andreoli, L. Coletto, G. Zanframundo, M. Govoni, L. Iaccarino, A. Tincani, A. Doria, R. Fischer-Betz, M. Mosca
Production of anti-{PF}4 antibodies in antiphospholipid antibody-positive patients is not affected by {COVID}-19 vaccination
2022 P.A. Lonati, C. Bodio, M. Scavone, G. Martini, E. Pesce, A. Bandera, A. Lombardi, M. Gerosa, F. Franceschini, A. Tincani, G. Podda, S. Abrignani, R. Grifantini, M.N. Cattaneo, M.O. Borghi, P. Luigi Meroni
Clinical and peculiar immunological manifestations of SARS-CoV-2 infection in systemic lupus erythematosus patients
2022 T. Schioppo, L.M. Argolini, S. Sciascia, F. Pregnolato, F. Tamborini, P. Miraglia, D. Roccatello, R.A. Sinico, R. Caporali, G. Moroni, M. Gerosa
Long-Term Clinical Outcome in Systemic Lupus Erythematosus Patients Followed for More Than 20 Years: The Milan Systemic Lupus Erythematosus Consortium (SMiLE) Cohort
2022 M. Gerosa, L. Beretta, G.A. Ramirez, E. Bozzolo, M. Cornalba, C. Bellocchi, L.M. Argolini, L. Moroni, N. Farina, G. Segatto, L. Dagna, R. Caporali
Myocardial involvement in anti-phospholipid syndrome: Beyond acute myocardial infarction
2022 L. Coletto, M. Gerosa, M. Valentini, R. Cimaz, R. Caporali, P. Meroni, C. Chighizola
Chronic glucocorticoid maintenance treatment is associated with the risk of SARS-CoV-2 infection in patients with systemic lupus erythematosus who received vaccination
2022 G.A. Ramirez, L.M. Argolini, T. Schioppo, S. Sciascia, L. Moroni, G. Moroni, R.A. Sinico, G. Bonelli, F. Alberici, F. Mescia, F. Tamborini, P. Miraglia, C. Bellocchi, L. Beretta, D. Roccatello, E.P. Bozzolo, R. Caporali, M. Gerosa, L. Dagna
Pregnancy in juvenile idiopathic arthritis: maternal and foetal outcome, and impact on disease activity
2022 M. Gerosa, C.B. Chighizola, F. Pregnolato, I. Pontikaki, A.F. Luppino, L. Maria Argolini, L. Trespidi, M. Wally Ossola, E.M. Ferrazzi, R. Caporali, R. Cimaz
Clinical Delphi on aPLnegativization: report from the from the APS Study Group of the Italian Society for Rheumatology (SIR-APS)
2022 S. Sciascia, S.G. Foddai, C. Alessandri, A. Alunno, L. Andreli, A. Barinotti, A. Calligaro, V. Canti, F. Carubbi, I. Cecchi, C.B. Chighizola, F. Conti, G. Emmi, A. Fioravanti, F. Fischetti, F. Franceschini, M. Gerosa, A. Hoxha, M. Larosa, M. Lazzaroni, C. Nalli, G. Pazzola, M. Radin, B. Raffeiner, V. Ramoni, E. Rubini, G.D. Sebastiani, S. Truglia, M.L. Urban, D. Roccatello, A. Tincani
Beyond Systemic Lupus Erythematosus and Anti-Phospholipid Syndrome: The Relevance of Complement From Pathogenesis to Pregnancy Outcome in Other Systemic Rheumatologic Diseases
2022 S. Cavalli, P.A. Lonati, M. Gerosa, R. Caporali, R. Cimaz, C.B. Chighizola
Low preconception complement levels are associated with adverse pregnancy outcomes in a multicenter study of 260 pregnancies in 197 women with antiphospholipid syndrome or carriers of antiphospholipid antibodies
2021 C. Nalli, D. Lini, L. Andreoli, F. Crisafulli, M. Fredi, M.G. Lazzaroni, V. Bitsadze, A. Calligaro, V. Canti, R. Caporali, F. Carubbi, C.B. Chighizola, P. Conigliaro, F. Conti, C. De Carolis, T. Del Ross, M. Favaro, M. Gerosa, A. Iuliano, J. Khizroeva, A. Makatsariya, P.L. Meroni, M. Mosca, M. Padovan, R. Perricone, P. Rovere-Querini, G.D. Sebastiani, C. Tani, M. Tonello, S. Truglia, D. Zucchi, F. Franceschini, A. Tincani
EUREKA algorithm predicts obstetric risk and response to treatment in women with different subsets of anti-phospholipid antibodies
2021 F. Pregnolato, M. Gerosa, M.G. Raimondo, C. Comerio, F. Bartoli, P.A. Lonati, M.O. Borghi, B. Acaia, M.W. Ossola, E. Ferrazzi, L. Trespidi, P.L. Meroni, C.B. Chighizola
Editorial: Therapeutic Implications for Pregnant Women With Systemic Autoimmune Diseases and Their Children
2021 C.B. Chighizola, G.R. de Jesus, M. Gerosa, T. Avcin
Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort
2021 M. Gatto, F. Saccon, L. Andreoli, E. Bartoloni, F. Benvenuti, A. Bortoluzzi, E. Bozzolo, E. Brunetta, V. Canti, P. Cardinaletti, F. Ceccarelli, F. Ciccia, F. Conti, G. De Marchi, A. de Paulis, S. De Vita, G. Emmi, P. Faggioli, S. Fasano, M. Fredi, A. Gabrielli, M. Gasparotto, R. Gerli, M. Gerosa, M. Govoni, E. Gremese, A. Laria, M. Larosa, M. Mosca, G. Orsolini, G. Pazzola, L. Petricca, G.A. Ramirez, F. Regola, F.W. Rossi, M. Rossini, C. Salvarani, S. Scarpato, C. Tani, A. Tincani, T. Ubiali, M.L. Urban, M. Zen, A. Doria, L. Iaccarino
Anti-phospholipid antibodies and reproductive failures
2021 A. Beltagy, L. Trespidi, M. Gerosa, M.W. Ossola, P.L. Meroni, C.B. Chighizola
COVID-19 and antiphospholipid antibodies: A position statement and management guidance from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION)
2021 X. Wang, E. Gkrouzman, D.C.O. Andrade, L. Andreoli, M. Barbhaiya, H.M. Belmont, D.W. Branch, G.R. de Jesus, M. Efthymiou, R. Rios-Garces, M. Gerosa, G. El Hasbani, J. Knight, P.L. Meroni, G. Pazzola, M. Petri, J. Rand, J. Salmon, M. Tektonidou, A. Tincani, I.W. Uthman, S. Zuily, Y. Zuo, M. Lockshin, H. Cohen, D. Erkan
Psychosocial burden in young patients with primary anti-phospholipid syndrome: an Italian nationwide survey (The AQUEOUS study)
2021 C. Chighizola, F. Crisafulli, A. Hoxha, F. Carubbi, M. Bellan, S. Monti, L. Costa, C. Baldi, M. Radin, E. Praino, L. Coletto, F. Pregnolato, S. Sciascia, P. Sainaghi, E. Bellis, V. Ramoni, L. Quartuccio, A. Alunno, M. Gerosa, L. Andreoli
Are patients with systemic lupus erythematosus at increased risk for COVID-19?
2021 E.G. Favalli, M. Gerosa, A. Murgo, R. Caporali